- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Human transforming growth factor β (TGFβ) receptor II
Total 100790 results
-
Eisai Inc.Halozyme TherapeuticsTerminated
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaUnited States
-
Seagen Inc.Array BioPharmaCompleted
-
University of Alabama at BirminghamTerminatedPenile Squamous Cell Carcinoma (PSCC)United States
-
RenJi HospitalUnknown
-
Novartis PharmaceuticalsCompletedPost Menopausal Breast CancerTaiwan, Malaysia, Turkey, Australia, Korea, Republic of, Thailand, Jordan, India, Vietnam, Morocco, Tunisia, Indonesia, South Africa
-
Horizon Pharma USA, Inc.Approved for marketingThyroid Eye Disease | Graves' OrbitopathyUnited States
-
Hoffmann-La RocheCompleted
-
Cellid Co., Ltd.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)UnknownRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia and other conditionsUnited States
-
Onco Medical Consult GmbHEli Lilly and Company; Institut fuer FrauengesundheitUnknownAdvanced Breast Cancer | Metastatic Breast Cancer
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | CD19 PositiveUnited States
-
Borstkanker Onderzoek GroepRoche Pharma AG; Teva PharmaCompletedMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastNetherlands
-
NYU Langone HealthMOUNT SINAI HOSPITALWithdrawn
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | de Novo Myelodysplastic Syndrome | Acute Biphenotypic LeukemiaUnited States
-
Hoffmann-La RocheTerminated
-
Institut de Recherches Internationales ServierBreast International GroupCompletedBreast CancerUnited Kingdom, Italy, France, Belgium, Australia, Canada, Germany, Hungary, Spain
-
The University of Texas Medical Branch, GalvestonNational Institutes of Health (NIH); National Institute of General Medical... and other collaboratorsTerminated
-
Genor Biopharma Co., Ltd.Unknown
-
National Cancer Institute (NCI)CompletedRenal Cell CarcinomaUnited States
-
Hoffmann-La RocheCompletedGastric Cancer | Gastroesophageal Junction CancerTurkey
-
Eli Lilly and CompanyCompletedAdenocarcinoma | Gastric CancerUnited States, Canada, Brazil, Czechia, Egypt, Korea, Republic of, Lebanon, Poland, Russian Federation, Spain, Romania, United Kingdom, Australia, Croatia, Italy, Philippines, Thailand, Argentina, Bosnia and Herzegovina, Chile, ... and more
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
Eli Lilly and CompanyTerminatedDiabetic Nephropathy | Diabetic Kidney Disease | Diabetic GlomerulosclerosisIsrael, Hungary, United States, Australia, France, Czechia, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Lymphoma | CD20 Positive | Lymphocytic NeoplasmUnited States
-
Hoffmann-La RocheCompletedBladder Cancer | Pancreas Cancer | Cholangiocellular CarcinomaSpain, Italy, Netherlands, Slovakia
-
National Cancer Institute (NCI)CompletedGlioblastoma | Brain Cancer | Malignant Glioma | GliosarcomaUnited States
-
Johannes Gutenberg University MainzPierre Fabre Pharma GmbHCompleted
-
GlaxoSmithKlineCompleted
-
AmgenActavis Inc.CompletedBreast CancerItaly, Hungary, Russian Federation, South Africa, Spain, Serbia, Belarus, Ukraine, Chile, Germany, Bulgaria, Greece, Poland, Canada, Brazil, Mexico, Romania, United Kingdom
-
Eli Lilly and CompanyAstraZenecaCompletedMetastatic Pancreatic CancerSpain, United States, Korea, Republic of, France, Italy
-
Henlix, IncTerminated
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)NSABP Foundation IncCompletedColon Adenocarcinoma | Stage IIIA Colon Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage IIIC Colon Cancer AJCC v7 | Stage IIA Colon Cancer AJCC v7 | Stage IIB Colon Cancer AJCC v7 | Stage IIC Colon Cancer AJCC v7United States
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous... and other conditionsUnited States, Korea, Republic of, Canada, Japan
-
Centro Nacional de Investigaciones Oncologicas...Fundacion CRIS de Investigación para Vencer el CáncerCompletedBreast Cancer | Early-Stage Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain
-
National Cancer Institute (NCI)NRG OncologyCompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Carcinoma | Stage IVB Cervical CancerUnited States, Spain
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Undifferentiated Ovarian CarcinomaUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Brenner Tumor | Stage II Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian... and other conditionsUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Brenner Tumor | Stage II Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian... and other conditionsUnited States, Japan
-
Shen LinUnknownColorectal Cancer | Esophageal Squamous Cell Carcinoma | Biliary Tract Cancer | Targeted Therapy | HER2China
-
Cairo UniversityCompletedAssisted ReproductionEgypt
-
Boehringer IngelheimCompletedBreast NeoplasmsHong Kong, Taiwan, United Kingdom, Russian Federation, India, Poland
-
Novartis PharmaceuticalsTerminatedCancerUnited States, Canada
-
Hoffmann-La RocheCompletedBreast CancerKazakhstan, Belarus
-
National Cancer Institute (NCI)CompletedMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
University of California, San DiegoUniversity of VirginiaCompleted
-
National Cancer Institute (NCI)CompletedRectal Adenocarcinoma | Stage III Rectal Cancer AJCC v7 | Stage II Rectal Cancer AJCC v7United States